Subjective Patient-Reported Versus Objective Adherence to Subcutaneous Interferon Β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study

BMC Neurology - United Kingdom
doi 10.1186/s12883-017-0952-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Seasonal Adherence To, and Effectiveness Of, Subcutaneous Interferon Β-1a Administered by RebiSmart® in Patients With Relapsing Multiple Sclerosis: Results of the 1-Year, Observational GEPAT-SMART Study

BMC Neurology
MedicineNeurology
2018English

Adherence to Self-Administering Interferon-Β1a Using RebiSmart® Device in Mexican Patients With Relapsing Multiple Sclerosis

PLoS ONE
Multidisciplinary
2020English

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Multiple Sclerosis
Neurology
2011English

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Network Analysis of Transcriptional Regulation in Response to Intramuscular Interferon-Β-1a Multiple Sclerosis Treatment

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2010English

Subcutaneous Interferon Β-1a in Pediatric Patients With Multiple Sclerosis: Regional Differences in Clinical Features, Disease Management, and Treatment Outcomes in an International Retrospective Study

Journal of the Neurological Sciences
Neurology
2016English

Objective Versus Self-Reported Adherence to Airway Clearance Therapy in Cystic Fibrosis

Respiratory Care
MedicinePulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2018English

Patient-Rated Suitability of a Novel Electronic Device for Self-Injection of Subcutaneous Interferon Beta-1a in Relapsing Multiple Sclerosis: An International, Single-Arm, Multicentre, Phase IIIb Study

BMC Neurology
MedicineNeurology
2010English

Prm89 - Database Analysis of a PSP (Patient Support Program) for Patients Using Interferon Beta-1a for Relapsing Multiple Sclerosis in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy